Charles River Laboratories International, Inc. Share Price BOERSE MUENCHEN
Equities
RV6
US1598641074
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
200.1 EUR | -0.55% | -3.13% | -6.20% |
Sales 2024 * | 4.22B 3.89B 331B | Sales 2025 * | 4.53B 4.18B 356B | Capitalization | 11.19B 10.32B 879B |
---|---|---|---|---|---|
Net income 2024 * | 406M 374M 31.88B | Net income 2025 * | 513M 473M 40.28B | EV / Sales 2024 * | 3.11 x |
Net Debt 2024 * | 1.94B 1.79B 153B | Net Debt 2025 * | 1.46B 1.34B 114B | EV / Sales 2025 * | 2.79 x |
P/E ratio 2024 * |
27.5
x | P/E ratio 2025 * |
22.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Charles River Laboratories International, Inc.
1 week | -1.86% | ||
Current month | -6.41% | ||
1 month | -10.55% | ||
3 months | -12.77% | ||
6 months | +11.60% | ||
Current year | -6.71% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 31/12/75 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 24/04/22 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 31/03/89 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 31/12/02 |
Virginia Wilson
BRD | Director/Board Member | 68 | 30/09/19 |
Robert Bertolini
BRD | Director/Board Member | 61 | 24/01/11 |
Date | Price | Change |
---|---|---|
24/05/24 | 200.1 | -0.55% |
23/05/24 | 201.2 | -0.64% |
22/05/24 | 202.5 | 0.00% |
21/05/24 | 202.5 | -0.83% |
20/05/24 | 204.2 | +0.15% |
Real-time BOERSE MUENCHEN, May 24, 2024 at 08:44 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.53% | 62.86B | |
-0.77% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+13.30% | 26.46B | |
-22.79% | 18.9B | |
+4.70% | 12.67B | |
+24.10% | 12.27B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- CRL Stock
- RV6 Stock